Ustekinumab treats psoriasis by suppressing RORC and T-box but its suppression of GATA restrains its efficacy. Braz. J. Pharm. Sci. [Internet]. 2018 Dec. 20 [cited 2024 Jun. 2];54(4):e17349. Available from: https://periodicos.usp.br/bjps/article/view/159278